Literature DB >> 12617969

Biochemical and ultrastructural analyses of IgLON cell adhesion molecules, Kilon and OBCAM in the rat brain.

S Miyata1, N Matsumoto, K Taguchi, A Akagi, T Iino, N Funatsu, S Maekawa.   

Abstract

Kilon (kindred of IgLON) and opioid-binding cell adhesion molecule belong to the IgLON subgroup of immunoglobulin superfamily together with the limbic system-associated membrane protein and neurotrimin. In the present study, we have analyzed biochemical and ultrastructural characterization of Kilon and opioid-binding cell adhesion molecule such as regional and developmental expression patterns, light and electron microscopic localization, and intermolecular interactions. Western blotting revealed a widespread distribution pattern of Kilon with high expression levels in the olfactory bulb, cerebral cortex, diencephalon, hippocampus, and cerebellum and low expression levels in the medulla oblongata and spinal cord. In contrast, opioid-binding cell adhesion molecule showed a regionally restricted expression pattern with high levels only in the cerebral cortex and hippocampus. Expression of Kilon and opioid-binding cell adhesion molecule was increased gradually during postnatal development and maintained until adulthood. Light microscopic immunohistochemistry demonstrated that the localization of opioid-binding cell adhesion molecule and Kilon coincided well with that of vesicle-associated membrane protein 2, a synaptic marker protein, in the cerebral cortex and hippocampus of adult brain. In the cerebellum, Kilon-immunoreactive puncta were observed to colocalize well with that of vesicle-associated membrane protein 2, while opioid-binding cell adhesion molecule immunoreactivity was observed only at part of synaptic glomeruli in the granular layer and rare in the molecular layer. Electron microscopic analysis revealed that Kilon and opioid-binding cell adhesion molecule immunoreactivity was observed mainly at postsynaptic sites of dendritic and somatic synapses in adult cerebral cortex and hippocampus. Only trace levels of Kilon and opioid-binding cell adhesion molecule were detected in the soluble fraction of a cortical homogenate, although a substantial amount of F3 was present in the soluble fraction. A binding analysis using a cross-linker and the immunoprecipitation technique demonstrated that Kilon and opioid-binding cell adhesion molecule interacted heterophilically and homophilically. These findings show that Kilon and opioid-binding cell adhesion molecule are clearly distinguishable from each other in regional expression and localization, and binding patterns. These differences possibly represent diverse functions of each IgLON molecule. Copyright 2003 IBRO

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12617969     DOI: 10.1016/s0306-4522(02)00873-4

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  19 in total

1.  In silico approach to identify non-synonymous SNPs with highest predicted deleterious effect on protein function in human obesity related gene, neuronal growth regulator 1 (NEGR1).

Authors:  Permendra Kumar; Kulandaivelu Mahalingam
Journal:  3 Biotech       Date:  2018-11-01       Impact factor: 2.406

2.  IgLON cell adhesion molecules are shed from the cell surface of cortical neurons to promote neuronal growth.

Authors:  Ricardo Sanz; Gino B Ferraro; Alyson E Fournier
Journal:  J Biol Chem       Date:  2014-12-23       Impact factor: 5.157

Review 3.  Neural immunoglobulin superfamily interaction networks.

Authors:  Kai Zinn; Engin Özkan
Journal:  Curr Opin Neurobiol       Date:  2017-05-27       Impact factor: 6.627

4.  A Proteomic Screen of Neuronal Cell-Surface Molecules Reveals IgLONs as Structurally Conserved Interaction Modules at the Synapse.

Authors:  Fanomezana M Ranaivoson; Liam S Turk; Sinem Ozgul; Sumie Kakehi; Sventja von Daake; Nicole Lopez; Laura Trobiani; Antonella De Jaco; Natalia Denissova; Borries Demeler; Engin Özkan; Gaetano T Montelione; Davide Comoletti
Journal:  Structure       Date:  2019-04-04       Impact factor: 5.006

5.  Age and diet shape the genetic architecture of body weight in diversity outbred mice.

Authors:  Kevin M Wright; Anil Raj; Andrew G Deighan; Andrea Di Francesco; Adam Freund; Vladimir Jojic; Gary A Churchill
Journal:  Elife       Date:  2022-07-15       Impact factor: 8.713

6.  Expression of ovarian tumour suppressor OPCML in the female CD-1 mouse reproductive tract.

Authors:  Jean S Fleming; H James McQuillan; Melanie J Millier; Grant C Sellar
Journal:  Reproduction       Date:  2009-01-27       Impact factor: 3.906

7.  A cell surface biotinylation assay to reveal membrane-associated neuronal cues: Negr1 regulates dendritic arborization.

Authors:  Francesca Pischedda; Joanna Szczurkowska; Maria Daniela Cirnaru; Florian Giesert; Elena Vezzoli; Marius Ueffing; Carlo Sala; Maura Francolini; Stefanie M Hauck; Laura Cancedda; Giovanni Piccoli
Journal:  Mol Cell Proteomics       Date:  2013-12-31       Impact factor: 5.911

Review 8.  Emerging roles for the GPI-anchored tumor suppressor OPCML in cancers.

Authors:  Jane Antony; Elisa Zanini; James R Birtley; Hani Gabra; Chiara Recchi
Journal:  Cancer Gene Ther       Date:  2020-06-29       Impact factor: 5.987

Review 9.  The Role of Synaptic Cell Adhesion Molecules and Associated Scaffolding Proteins in Social Affiliative Behaviors.

Authors:  Sara C Taylor; Sarah L Ferri; Mahip Grewal; Zoe Smernoff; Maja Bucan; Joshua A Weiner; Ted Abel; Edward S Brodkin
Journal:  Biol Psychiatry       Date:  2020-02-22       Impact factor: 12.810

10.  Functional inactivation of the genome-wide association study obesity gene neuronal growth regulator 1 in mice causes a body mass phenotype.

Authors:  Angela W S Lee; Heidi Hengstler; Kathrin Schwald; Mauricio Berriel-Diaz; Desirée Loreth; Matthias Kirsch; Oliver Kretz; Carola A Haas; Martin Hrabě de Angelis; Stephan Herzig; Thomas Brümmendorf; Martin Klingenspor; Fritz G Rathjen; Jan Rozman; George Nicholson; Roger D Cox; Michael K E Schäfer
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.